Strategic Financial Services’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
CIS
GAM
MWM
Strategic Financial Services's SBIO Position: Q1 2026 in Review
Strategic Financial Services reduced its ALPS Medical Breakthroughs ETF (SBIO) stake by 25% in Q1 2026, selling an estimated $419K and leaving 24,869 shares worth $1.3M. The position accounts for 0.06% of the portfolio, ranked #62.
Strategic Financial Services first reported a position in SBIO in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.75M in Q3 2023. 59 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.
- Strategic Financial Services held 24,869 shares of ALPS Medical Breakthroughs ETF worth $1.3M as of Q1 2026.
- Strategic Financial Services sold 8,234 ALPS Medical Breakthroughs ETF shares in Q1 2026, an estimated $419K.
- ALPS Medical Breakthroughs ETF made up 0.06% of Strategic Financial Services's portfolio in Q1 2026, its #62 holding.
- Strategic Financial Services first reported a position in ALPS Medical Breakthroughs ETF in Q4 2021 and has held it in 18 quarters since.
- Strategic Financial Services's ALPS Medical Breakthroughs ETF position peaked at $1.75M in Q3 2023.
- 59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.
Based on Strategic Financial Services's 13F filing for Q1 2026, filed 8 May 2026.